Correlation Between Alcoa Corp and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alcoa Corp and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alcoa Corp and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alcoa Corp and Intellia Therapeutics, you can compare the effects of market volatilities on Alcoa Corp and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alcoa Corp with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alcoa Corp and Intellia Therapeutics.
Diversification Opportunities for Alcoa Corp and Intellia Therapeutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Alcoa and Intellia is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Alcoa Corp and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Alcoa Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alcoa Corp are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Alcoa Corp i.e., Alcoa Corp and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Alcoa Corp and Intellia Therapeutics
Allowing for the 90-day total investment horizon Alcoa Corp is expected to generate 0.68 times more return on investment than Intellia Therapeutics. However, Alcoa Corp is 1.48 times less risky than Intellia Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 4,131 in Alcoa Corp on August 27, 2024 and sell it today you would earn a total of 416.00 from holding Alcoa Corp or generate 10.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Alcoa Corp vs. Intellia Therapeutics
Performance |
Timeline |
Alcoa Corp |
Intellia Therapeutics |
Alcoa Corp and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alcoa Corp and Intellia Therapeutics
The main advantage of trading using opposite Alcoa Corp and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alcoa Corp position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.The idea behind Alcoa Corp and Intellia Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |